Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global pegfilgrastim biosimilars market.
Description: Where is the largest and fastest growing market for the pegfilgrastim biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global pegfilgrastim biosimilars market opportunities and strategies to 2030 report answers all these questions and many more.
The report covers the following chapters • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report • Report Structure – This section gives the structure of the report and the information covered in the various sections. • Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by target antigen and by application. • Market Characteristics – The market characteristics section of the report defines and explains the pegfilgrastim biosimilars market. This chapter includes different services covered in the report and basic definitions. • Trends And Strategies – This chapter describes the major trends shaping the global pegfilgrastim biosimilars market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities. • COVID Impact Analysis – This section provides an insight on how the pandemic is impacting the pegfilgrastim biosimilars market. • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2023F, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods. • Regional Analysis – This section contains the historic (2015-2019), forecast (2019-2023F, 2025F, 2030F) market value and growth and market share comparison by region. • Market Segmentation – This section contains the market values (2015-2019, 2019-2023F, 2025F, 2030F) and analysis for segment by type in the market. • Regional Market Size And Growth – This section contains the region’s market size (2019), historic and forecast (2015-2019, and 2023F, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa). • Competitive Landscape – This section covers details on the competitive landscape of the global pegfilgrastim biosimilars market, estimated market shares and company profiles of the leading players. • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years. • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years. • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for pegfilgrastim biosimilars companies in terms of product offerings, geographic expansion, marketing strategies and target groups. • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered: The global pegfilgrastim biosimilars market is segmented into - By Application: Chemotherapy Induced Neutropenia; Transplantation; Others By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail Order/ Online Pharmacies
Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Gain a global perspective on the development of the market.
Our reports have been used by over 10K customers, including:
The global biologics CDMO market (henceforth, referred to as the market studied) was valued at USD 9.93 billion in 2020, and it is expected to reach USD 18.90 billion by 2026, registering a CAGR of 11.2% during 2021-2026 (henceforth, referred to as the forecast period).? - The global pharmaceutical industry is growing at an exponential...
The global recombinant proteins market is projected to reach USD 1.7billion by 2026 from USD 1.0billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industryacademia collaborations,...
The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% during the forecast period. Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects...
The fill finish manufacturing market was valued at US$ 6,129.03 million in 2019 and is projected to reach US$ 12,547.23 million by 2027; it is expected to grow at a CAGR of 9.6% from 2020 to 2027. The growth of the fill finish manufacturing market is mainly attributed to factors such as rising adoption of prefilled syringes for parenteral...
The anti-money laundering solution market was valued at US$ 1,503.99 million in 2019 and is projected to reach US$ 5,866.51 million by 2027; it is expected to grow at a CAGR of 16.2% from 2020 to 2027. Transaction monitoring is a crucial procedure and key control in anti-money laundering (AML) and countering the financing of terrorism (AML/CFT)...
The whole slide imaging market was valued at US$ 419.52 million in 2019 and is projected to reach US$ 1,582.12 million by 2027; it is expected to grow at a CAGR of 18.1% during 2020–2027. Technological advancements in whole slide imaging and increase in adoption of digital pathology. However, the high cost involved in the installation and...
317 pages •
By The Business Research Company
• Oct 2020
Oral Biologics & Biosimilars Global Market Opportunities And Strategies To 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global oral biologics and biosimilars market.
Where is the largest and fastest growing market for the oral...
The global biologics CDMO market (henceforth, referred to as the market studied) was valued at USD 8.89 billion in 2019, and it is expected to reach USD 16.9 billion by 2025, registering a CAGR of 11.2% during 2020-2025 (henceforth, referred to as the forecast period).?
- The global pharmaceutical industry is growing at an exponential...
The global single-use bioreactors market is projected to reach USD 3.9 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 18.0% during the forecast period. Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption,...
On the mend: The recovery of the Canadian economy will likely support demand for new patented medicines and therapies Abstract Brand-Name Pharmaceutical Manufacturing in Canada The Brand-name Pharmaceutical industry in Canada has endured strong competitive pressures from generic drugs by innovating...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.